Dialysis – Transplantation

Kidney International (2004) 66, 2047–2053; doi:10.1111/j.1523-1755.2004.00977.x

Screening for depression in hemodialysis patients: Associations with diagnosis, treatment, and outcomes in the DOPPS

ANTONIO ALBERTO LOPES, JUSTIN M ALBERT, ERIC W YOUNG, SUDTIDA SATAYATHUM, RONALD L PISONI, VITTORIO E ANDREUCCI, DONNA L MAPES, NANCY A MASON, SHUNICHI FUKUHARA, BJÖRN WIKSTRÖM, AKIRA SAITO and FRIEDRICH K PORT

Department of Medicine, Federal University of Bahia, Bahia, Brazil; University Renal Research and Education Association, Ann Arbor, Michigan; Division of Nephrology, University of Michigan and Veterans Administration Medical Center, Ann Arbor, Michigan; Universita Federico II, Naples, Italy; Amgen, Inc., Thousand Oaks, California; College of Pharmacy, University of Michigan, Ann Arbor, Michigan; Tokai University School of Medicine, Isehara, Kanagawa, Japan; and Institutionen for Medicinska Vetenskaper, Medicin Akademiska Sjukhuset, Uppsala, Sweden

Correspondence: Friedrich K. Port, M.D., M.S., University Renal Research and Education Association, 315 W. Huron, Suite 260, Ann Arbor, MI 48103. E-mail:dopps@urrea.org

Received 29 January 2004; Revised 14 May 2004; Accepted 27 May 2004.

Top

Abstract

Screening for depression in hemodialysis patients: Associations with diagnosis, treatment, and outcomes in the DOPPS.

Background

 

Depressive symptoms and depression are the most frequent psychologic problems reported by hemodialysis patients. We assessed the prevalence of depressive symptoms and physician-diagnosed depression, their variations by country, and associations with treatment by antidepressants among hemodialysis patients. We also assessed whether depressive symptoms were independently associated with mortality, hospitalization, and dialysis withdrawal.

Methods

 

The sample was represented by 9382 hemodialysis patients randomly selected from dialysis centers of 12 countries enrolled in the Dialysis Outcomes and Practice Patterns Study (DOPPS II). Depressive symptoms were assessed by the short version of the Center for Epidemiological Studies Depression Screening Index (CES-D), using greater than or equal to10 CES-D score as the cut-off value.

Results

 

Overall prevalence of physician-diagnosed depression was 13.9%, and percentage of CES-D score greater than or equal to10 43.0%. While the smallest prevalence of physician-diagnosed depression was observed in Japan (2.0%) and France (10.6%), the percentage of CES-D score greater than or equal to10 in these counties was similar to the whole sample. Patients on antidepressants also varied by country, 34.9% and 17.3% among those with physician-diagnosed depression and CES-D scores greater than or equal to10, respectively. In Cox models adjusted for several comorbidities, CES-D scores greater than or equal to10 were associated with significantly higher relative risks (RR) of death (RR = 1.42; 95% CI = 1.29 to 1.57), hospitalization (RR = 1.12; 95% CI = 1.03 to 1.22), and dialysis withdrawal (RR = 1.55; 95% CI = 1.29 to 1.85).

Conclusion

 

The data suggest that depression is underdiagnosed and undertreated among hemodialysis patients. CES-D can help identify hemodialysis patients who are at higher risk of death and hospitalization. Interventions should target these patients with the goal to improve survival and reduce hospitalizations.

Keywords:

depression, dialysis, end-stage renal disease, hospitalization, mortality

Extra navigation

.
ADVERTISEMENT